E-LIB Suche - Ergebnisse für: Wu, Yilong

1

Immunotherapy in resectable NSCLC: Answering the question o..:

Liu, Si-Yang ; Feng, Wei-Neng ; Wu, Yi-Long
Cancer Cell. 42 (2024) 5 - p. 727-731 , 2024

Link: https://doi.org/10.1016/..

2

Effect of tree roots on heavy rainfall-induced shallow land..:

Lin, Yunzhao ; Jian, Wenbin ; Wu, Yilong...
Geomatics, Natural Hazards and Risk. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

3

Carboxylate trapping engineering to fabricate monodispersed..:

Chu, Hailiang ; Wu, Yilong ; Qiu, Shujun...
Inorganic Chemistry Frontiers. 11 (2024) 8 - p. 2260-2271 , 2024

Link: https://doi.org/10.1039/..

4

A novel small‐animal locomotor activity recording device fo..:

Wu, Yi‐Long ; Zhong, Ming ; Yin, Jun...
Animal Models and Experimental Medicine. 7 (2024) 1 - p. 71-76 , 2024

Link: https://doi.org/10.1002/..

5

PD-L1 expression guidance on sintilimab versus pembrolizuma..:

Maggie Liu, Si-Yang ; Huang, Jie ; Deng, Jia-Yi...
Science Bulletin. 69 (2024) 4 - p. 535-543 , 2024

Link: https://doi.org/10.1016/..

6

Adjuvant Therapy-Free Strategy for Stage IB to IIIA Non–Sma..:

Zhang, Jia-Tao ; Dong, Song ; Gu, Wei-Quan...
Clinical Lung Cancer. 25 (2024) 1 - p. e1-e4 , 2024

Link: https://doi.org/10.1016/..

7

Plasma ddPCR for the detection of MET amplification in adva..:

Su, Jun-Wei ; Weng, Cheng-Di ; Lin, Xiao-Cheng...
Therapeutic Advances in Medical Oncology. 16 (2024) - p. , 2024

Link: https://doi.org/10.1177/..

8

Neoadjuvant and Adjuvant Treatment for Early-Stage Resectab..:

Spicer, Jonathan D. ; Cascone, Tina ; Wynes, Murry W....
Journal of Thoracic Oncology. , 2024

Link: https://doi.org/10.1016/..

9

Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSC..:

Zhang, Chao ; Sun, Yu-Xuan ; Yi, Ding-Cheng...
Cell Reports Medicine. , 2024

Link: https://doi.org/10.1016/..

10

Plasma EBV quantification is associated with the efficacy o..:

Zhong, Yu‐Min ; Chen, Ji ; Jiang, Jie...
Clinical & Translational Immunology. 13 (2024) 6 - p. , 2024

Link: https://doi.org/10.1002/..

11

Redoxhighphenotype mediated by KEAP1/STK11/SMARCA4/NRF2 mut..:

Wei, Xue-Wu ; Lu, Chang ; Zhang, Yi-Chen...
OncoImmunology. 13 (2024) 1 - p. , 2024

Link: https://doi.org/10.1080/..

12

Neoadjuvant SHR-1701 with or without chemotherapy in unrese..:

Zhou, Qing ; Pan, Yi ; Yang, Xuening...
Cancer Cell. , 2024

Link: https://doi.org/10.1016/..

13

Updated Efficacy and Safety of Lorlatinib in a Phase 2 Stud..:

Lu, Shun ; Zhou, Qing ; Liu, Xiaoqing...
Clinical Lung Cancer. , 2024

Link: https://doi.org/10.1016/..

14

Allelic Context of EGFR C797X–Mutant Lung Cancer Defines Fo..:

Lu, Chang ; Wei, Xue-Wu ; Wang, Zhen...
Journal of Thoracic Oncology. 19 (2024) 4 - p. 601-612 , 2024

Link: https://doi.org/10.1016/..

15

HERTHENA-Lung02: phase III study of patritumab deruxtecan i..:

Mok, Tony ; Jänne, Pasi A ; Nishio, Makoto...
Future Oncology. 20 (2024) 15 - p. 969-980 , 2024

Link: https://doi.org/10.2217/..